Calvin Chen

Calvin Chen is an accomplished professional with extensive experience in corporate development, investment, and board leadership across various industries. Currently serving as the Director of Corporate Development & Investment at WuXi Biologics since September 2022, Calvin has held influential roles including Board Member at Perceptive Medical and ECFX, where ECFX focuses on automation solutions for the legal sector. Calvin contributes to the Cove Fund as a member of the Investment Committee, which specializes in seed-stage investments, and participates in the Southern California Biomedical Council's Innovation Catalyst Program Screening Committee. Previous positions include Associate Director of Alliance Management at Ionis Pharmaceuticals and CEO of CrossLinkBio, an accelerator for biomedical innovations that connects US and Chinese startups. Calvin's educational background includes a BA in Molecular Biology and Psychology from the University of California, Berkeley, and a J.D. from Loyola Law School, Los Angeles.